Thursday, March 14, 2019 11:24:28 AM
IMHO the medical breathalyzer is our best shot for superstardom here. That is technology that can change the industry. Money spent developing this technology would put ALGERNON on a map where others don't exist. This could draw far more big Pharma money.....and they don't have that pesky 70% failure rate....that drug repurposing does.
The medical diseases ALGERNON is researching compounds for.....are serious and need better drugs than currently available. IF ALGERNON's mystery compounds could somehow skip Phase I and begin Phase II trials...we face a 70% failure rate...trying to get through FDA approval
We have four mystery compounds that have risen to the top of our search for repurposing drugs in needed fields. At $30 million each to get through trials.....we need $120 million dollars.
If we have great results after our mouse trials...where will the money come from?
Pharma money could turn the medical breathalyzer into a goldmine....with the list of diseases it could detect able to be added as development went on.
GLTA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM